SLCC_CHRSD
ID SLCC_CHRSD Reviewed; 309 AA.
AC Q1QWN6;
DT 05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT 16-MAY-2006, sequence version 1.
DT 03-AUG-2022, entry version 113.
DE RecName: Full=(S)-sulfolactate dehydrogenase;
DE EC=1.1.1.310;
DE AltName: Full=(2S)-3-sulfolactate dehydrogenase;
DE AltName: Full=(S)-sulfolactate oxidoreductase;
GN Name=slcC; OrderedLocusNames=Csal_1770;
OS Chromohalobacter salexigens (strain ATCC BAA-138 / DSM 3043 / CIP 106854 /
OS NCIMB 13768 / 1H11).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Oceanospirillales;
OC Halomonadaceae; Chromohalobacter.
OX NCBI_TaxID=290398;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11;
RX PubMed=22675587; DOI=10.4056/sigs.2285059;
RA Copeland A., O'Connor K., Lucas S., Lapidus A., Berry K.W., Detter J.C.,
RA Del Rio T.G., Hammon N., Dalin E., Tice H., Pitluck S., Bruce D.,
RA Goodwin L., Han C., Tapia R., Saunders E., Schmutz J., Brettin T.,
RA Larimer F., Land M., Hauser L., Vargas C., Nieto J.J., Kyrpides N.C.,
RA Ivanova N., Goker M., Klenk H.P., Csonka L.N., Woyke T.;
RT "Complete genome sequence of the halophilic and highly halotolerant
RT Chromohalobacter salexigens type strain (1H11(T)).";
RL Stand. Genomic Sci. 5:379-388(2011).
RN [2]
RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC STRAIN=ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11;
RX PubMed=20007648; DOI=10.1099/mic.0.034736-0;
RA Denger K., Cook A.M.;
RT "Racemase activity effected by two dehydrogenases in sulfolactate
RT degradation by Chromohalobacter salexigens: purification of (S)-
RT sulfolactate dehydrogenase.";
RL Microbiology 156:967-974(2010).
CC -!- FUNCTION: Dehydrogenase of the (R,S)-sulfolactate degradation pathway
CC that only acts on the (S)-enantiomer of 3-sulfolactate. Together with
CC ComC, provides a racemase system that converts (2S)-3-sulfolactate to
CC (2R)-3-sulfolactate, which is degraded further by (2R)-sulfolactate
CC sulfo-lyase. Specific for NAD. Also able to form sulfolactate from
CC sulfopyruvate. {ECO:0000269|PubMed:20007648}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(2S)-3-sulfolactate + NAD(+) = 3-sulfopyruvate + H(+) + NADH;
CC Xref=Rhea:RHEA:28194, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC ChEBI:CHEBI:57940, ChEBI:CHEBI:57945, ChEBI:CHEBI:61289;
CC EC=1.1.1.310; Evidence={ECO:0000269|PubMed:20007648};
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=2 mM for NAD {ECO:0000269|PubMed:20007648};
CC KM=7 mM for (2S)-3-sulfolactate {ECO:0000269|PubMed:20007648};
CC -!- SIMILARITY: Belongs to the D-isomer specific 2-hydroxyacid
CC dehydrogenase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000285; ABE59122.1; -; Genomic_DNA.
DR RefSeq; WP_011507068.1; NC_007963.1.
DR AlphaFoldDB; Q1QWN6; -.
DR SMR; Q1QWN6; -.
DR STRING; 290398.Csal_1770; -.
DR EnsemblBacteria; ABE59122; ABE59122; Csal_1770.
DR KEGG; csa:Csal_1770; -.
DR eggNOG; COG0111; Bacteria.
DR HOGENOM; CLU_019796_1_3_6; -.
DR OMA; EQALFMM; -.
DR OrthoDB; 1638924at2; -.
DR BioCyc; MetaCyc:MON-15867; -.
DR Proteomes; UP000000239; Chromosome.
DR GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR GO; GO:0102155; F:S-sulfolactate dehydrogenase activity; IEA:UniProtKB-EC.
DR InterPro; IPR006139; D-isomer_2_OHA_DH_cat_dom.
DR InterPro; IPR029753; D-isomer_DH_CS.
DR InterPro; IPR006140; D-isomer_DH_NAD-bd.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR Pfam; PF00389; 2-Hacid_dh; 1.
DR Pfam; PF02826; 2-Hacid_dh_C; 1.
DR SUPFAM; SSF51735; SSF51735; 1.
DR PROSITE; PS00670; D_2_HYDROXYACID_DH_2; 1.
DR PROSITE; PS00671; D_2_HYDROXYACID_DH_3; 1.
PE 1: Evidence at protein level;
KW NAD; Oxidoreductase; Reference proteome.
FT CHAIN 1..309
FT /note="(S)-sulfolactate dehydrogenase"
FT /id="PRO_0000418761"
FT ACT_SITE 233
FT /evidence="ECO:0000250"
FT ACT_SITE 262
FT /evidence="ECO:0000250"
FT ACT_SITE 281
FT /note="Proton donor"
FT /evidence="ECO:0000250"
FT BINDING 151..152
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 171
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 231..233
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 257
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 281..284
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
SQ SEQUENCE 309 AA; 33135 MW; 4B2AC12D988EC3E1 CRC64;
MSDVLISEFM DEAAVADLER DCSVTFDATL VDDRARLLSS GAGVRALIVR NRTRVDRELL
ARFPDLRAVG RLGVGLDNID VDACRESDIA VLPATGGNTV SVAEYVLTGI FMLRRGAYLS
TPRVLAGEWP RQALMGHETQ GATLGLVGFG GIARDLARRA QCLGMQVMAH DPFVPADDAA
WQTVERAERL ATLLEKADAV SLHVPLSEGT RHLIDGEALA TMKPGSLLIN TARGGIVDER
ALAASLRDRH LGGAMLDVFE EEPLTADSVL SGVEGLIATP HIAGVTHESN ERISWITVDN
VRRALGVRA